Sudden Sensorineural Hearing Loss (SSNHL)
The condition that causes complete unilateral hearing loss benefiting from oral steroids is idiopathic sudden sensorineural hearing loss (SSNHL), defined as acute onset (within 72 hours) of unilateral hearing loss of 30 dB or greater across at least three contiguous frequencies, confirmed by audiometry. 1
Clinical Presentation
SSNHL typically presents with:
- Abrupt unilateral hearing loss (often noticed upon waking)
- Tinnitus (loud ringing)
- Vertigo or balance problems
- Aural fullness or pressure
- May be accompanied by nausea 1
The key distinguishing feature is the sudden onset - patients can often pinpoint the exact moment or day it occurred. This is an otologic emergency requiring urgent evaluation, ideally within 14 days of onset 1.
Diagnostic Confirmation
Audiometry is mandatory - you cannot diagnose SSNHL without formal hearing testing showing sensorineural pattern loss. Pure tone audiometry will demonstrate:
- Unilateral sensorineural hearing loss (air and bone conduction both affected)
- Loss of ≥30 dB across three contiguous frequencies
- In complete/profound cases: thresholds >90 dB with unobtainable speech reception threshold 2
Routine labs and imaging are not required initially, but MRI of internal auditory canals should be considered to exclude vestibular schwannoma (present in rare cases) 1.
Treatment Algorithm with Oral Steroids
First-Line: Systemic Corticosteroids
Initiate immediately, ideally within 14 days of onset (benefit reported up to 6 weeks but outcomes decline with delay) 1, 3:
Dosing options 1:
- Prednisone 1 mg/kg/day (usual max 60 mg/day) for 7-14 days, then taper over similar period
- Methylprednisolone 48 mg/day
- Dexamethasone 10 mg/day
Do not divide doses - give as single daily dose 1.
The evidence for systemic steroids is equivocal from randomized trials, but they remain standard of care based on guideline consensus and observational data showing benefit, particularly in severe cases 1, 4. A 2003 retrospective analysis demonstrated significant improvement (p<0.01) in severe-to-profound cases treated with steroids versus untreated patients 4.
Alternative: Intratympanic Steroids as Primary Therapy
For patients with contraindications to systemic steroids (insulin-dependent diabetes, poorly controlled hypertension, glaucoma, tuberculosis, peptic ulcer disease, psychiatric reactions to steroids), intratympanic (IT) steroid injection is non-inferior 1, 5:
- A 2011 randomized trial of 250 patients showed IT methylprednisolone was non-inferior to oral prednisone (PTA improvement 28.7 dB vs 30.7 dB, difference only 2.0 dB) 5
- IT dexamethasone 24 mg/mL or methylprednisolone 40 mg/mL
- 4 injections over 2 weeks
- Patient keeps head tilted (affected ear up) for 15-30 minutes after injection 1
Salvage Therapy for Incomplete Recovery
If hearing does not recover after initial treatment, offer intratympanic steroids as salvage therapy - this has the strongest evidence with Grade A recommendation 6:
- Salvage IT provides significant benefit (OR: 6.04,95% CI: 3.26-11.2, NNT≈3) 6
- Initiate after 2 weeks if initial therapy fails 1
- Same dosing protocol as primary IT therapy
Combined Initial Therapy Consideration
For severe to profound hearing loss specifically, recent evidence suggests combined systemic plus intratympanic steroids as initial therapy may be superior 7:
- Greater PTA improvement (31.0±10.0 dB vs 45.0±9.8 dB) and higher complete recovery rates (46.5% vs 29.4%, p=0.005) 7
- Improved speech discrimination (72.3% vs 57.4%, p=0.042) 7
- However, this represents newer evidence with moderate risk of bias, and the 2019 AAO-HNS guideline does not yet strongly endorse this as routine initial approach 1
Prognosis Factors
Better outcomes occur with 1, 3:
- Earlier treatment initiation (within first 2 weeks)
- Milder degree of initial hearing loss
- Recovery of at least half the hearing within first 2 weeks predicts better final outcome
- Absence of vertigo at onset
Poorer prognosis 1:
- Presence of dizziness/vertigo at onset
- Profound initial hearing loss
- Delayed presentation beyond 2 weeks
- Minimal change within first 2 weeks
Approximately one-third to two-thirds of patients recover some hearing spontaneously within 2 weeks, which complicates interpretation of treatment efficacy 1.
Monitoring
- Audiogram at completion of treatment (2 months) and delayed intervals 1
- Follow-up audiometry within 6 months of diagnosis 1
- For IT injections: interval audiograms between injections may guide early termination if hearing resolves 1
- Inspect tympanic membrane for healing after IT therapy 1
Critical Pitfalls
Shared decision-making is essential given equivocal evidence for systemic steroids and potential adverse effects 1. However, adverse events are rare and manageable with the short 10-14 day course recommended (most serious effects occur with chronic use) 1.
Common steroid side effects include hyperglycemia, weight gain, insomnia, hypertension, mood changes, and gastric irritation 1. Monitor glucose and blood pressure in susceptible patients 1.
Do not delay treatment waiting for spontaneous recovery - the window for maximal benefit is narrow, and early intervention correlates with better outcomes 3.